Pharma Stocks News

Small Cap Pharma Stock Grew 166% In 3 Years, Brokerage Sees 30% Upside, Assigns Buy

Small Cap Pharma Stock Grew 166% In 3 Years, Brokerage Sees 30% Upside, Assigns Buy

Axis Securities Picks This Large Cap Pharma Stock, Shares Likely To Surge, Recommends Buy

Axis Securities Picks This Large Cap Pharma Stock, Shares Likely To Surge, Recommends Buy

Kotak Securities Retains ADD Rating On This Pharma Stock, Target Price Rs 1,120, Sees Strong Upside

Kotak Securities Retains ADD Rating On This Pharma Stock, Target Price Rs 1,120, Sees Strong Upside

Sharekhan Bullish On This Multibagger Small Cap Auto Ancillary Stock, Buy For Robust 38% Gains

Sharekhan Bullish On This Multibagger Small Cap Auto Ancillary Stock, Buy For Robust 38% Gains

KR Choksey Bullish On This Small Cap Pharma Stock, Sees 45% Potential Upside, Buy

KR Choksey Bullish On This Small Cap Pharma Stock, Sees 45% Potential Upside, Buy

Buy This Multibagger Small Cap Pharma Stock, ICICI Direct Sees 33% Returns In 12 Months

Buy This Multibagger Small Cap Pharma Stock, ICICI Direct Sees 33% Returns In 12 Months

Buy This Small Cap Pharma Stock For Gains Up 26%, Target Price Rs 955: ICICI Direct

Buy This Small Cap Pharma Stock For Gains Up 26%, Target Price Rs 955: ICICI Direct

Prabhudas Lilladher Bullish On This Multibagger Tata Group Stock,  Maintains Buy For 26% Returns

Prabhudas Lilladher Bullish On This Multibagger Tata Group Stock,  Maintains Buy For 26% Returns

ICICI Direct Upgrades Rating From HOLD To BUY On Small Cap Pharma Stock, Sees 20% Gains In 12 Months

ICICI Direct Upgrades Rating From HOLD To BUY On Small Cap Pharma Stock, Sees 20% Gains In 12 Months

Buy This Multibagger Small Cap Pharma Stock, Shares Can Jump 15%: Axis Securities

Buy This Multibagger Small Cap Pharma Stock, Shares Can Jump 15%: Axis Securities

Buy This Large Cap Pharma Stock For 16% Potential Upside, Revenues Grew 9.4% YoY, Says ICICI Direct

Buy This Large Cap Pharma Stock For 16% Potential Upside, Revenues Grew 9.4% YoY, Says ICICI Direct

ICICI Direct Places Buy Call On This Mid Cap Pharma Stock, Sees 23% Potential Upside

ICICI Direct Places Buy Call On This Mid Cap Pharma Stock, Sees 23% Potential Upside

Buy This Multibagger Large Cap Pharma Stock, Target Price Rs 1,724: Anand Rathi

Buy This Multibagger Large Cap Pharma Stock, Target Price Rs 1,724: Anand Rathi

Buy This Mid-Cap Pharma Stock For Target Price Of Rs 645, Q1FY23 Revenue Rose 9.4% YoY: Geojit

Buy This Mid-Cap Pharma Stock For Target Price Of Rs 645, Q1FY23 Revenue Rose 9.4% YoY: Geojit

This Recently Listed Small Cap Pharma Stock Likely To Surge 15%, Brokerage Rates Accumulate

This Recently Listed Small Cap Pharma Stock Likely To Surge 15%, Brokerage Rates Accumulate

This Small Cap Pharma Stock Likely To Surge 18%, Brokerage Estimates Target Price of Rs 410

This Small Cap Pharma Stock Likely To Surge 18%, Brokerage Estimates Target Price of Rs 410

Stock To Buy: Dr Reddy's Labs Gets Buy Call For 23% Gains, Check What's Target Price

Stock To Buy: Dr Reddy's Labs Gets Buy Call For 23% Gains, Check What's Target Price

Syngene International Gets 'Buy' Call For 24% Potential Upside, Recommended By ICICI Securities

Syngene International Gets 'Buy' Call For 24% Potential Upside, Recommended By ICICI Securities

Notifications
Settings
Clear Notifications
Notifications
Use the toggle to switch on notifications
  • Block for 8 hours
  • Block for 12 hours
  • Block for 24 hours
  • Don't block
Gender
Select your Gender
  • Male
  • Female
  • Others
Age
Select your Age Range
  • Under 18
  • 18 to 25
  • 26 to 35
  • 36 to 45
  • 45 to 55
  • 55+